The role of β2-glycoprotein I (β2GPI) in the activation of plasminogen

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1764, Issue 4, 2006, Pages 815-823

  López Lira, Francisco ^a,b   Rosales León, Luis ^a   Martínez, Verónica Monroy ^a   Ruiz Ordaz, Blanca H ^a  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

^b HOSPITAL GENERAL DE MÉXICO   (Mexico)

Author keywords

2 glycoprotein; Fibrinolysis; Plasmin; Plasminogen activation; Thrombosis

Indexed keywords

BETA2 GLYCOPROTEIN 1; FIBRIN; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE 1; PLASMINOGEN; ANTIBODY; GLYCOPROTEIN; THROMBOMODULIN;

ARTICLE; CELL SURFACE; FIBRINOLYSIS; HUMAN; MOLECULAR DYNAMICS; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN INTERACTION; VASCULAR ENDOTHELIUM; BIOSYNTHESIS; CELL CULTURE; ENZYME ACTIVATION; IMMUNOLOGY; KRINGLE DOMAIN; METABOLISM; PHYSIOLOGY;

ANTIBODIES; BETA 2-GLYCOPROTEIN I; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; FIBRINOLYSIS; GLYCOPROTEINS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; KRINGLES; PLASMINOGEN; THROMBOMODULIN;

EID: 33745157186     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2005.12.020     Document Type: Article

References (32)

1. Kandiah D.A., and Krilis S.A. βeta-2-glycoprotein I. Lupus 3 (1994) 207-212
2. Hunt J.E., Simpson R.J., and Krilis S.A. Identification of a region of β2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 2141-2145
3. McNeil H.P., Simpson R.J., Chesterman C.N., and Krilis S.A. Anti-phospholipid antibodies are directed against a complex antigen that induces a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H). Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 4120-4124
4. Kandiah D.A., Sali A., Sheng Y., Victoria E.J., Marquis D.M., Coutts S.M., and Krilis S.A. Current insights into the "antiphospholipid" syndrome: clinical, immunological, and molecular aspects. Adv. Immunol. 70 (1998) 507-563
5. Hughes G.R.V. The antiphospholipid syndrome: ten years on. Lancet 342 (1993) 341-344
6. Schousboe I. βeta-2-glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. Blood 66 (1985) 1086-1091
7. Mori T., Takeya H., Nishioka J., Gabazza E.C., and Suzuki K. β2-glycoprotein I modulates the anticoagulant activity of activated protein C on the phospholipid surface. Thromb. Haemost. 75 (1996) 49-55
8. 2-glycoprotein I to human serum lipoproteins. Distribution among density fractions. FEBS Lett. 102 (1979) 183-186
9. Wurm H., Beubler E., Polz E., Holasek A., and Kostner G. Studies on the possible function of β2-glycoprotein I: influence in the triglyceride metabolism in rat. Metabolism 31 (1982) 484-486
10. Kochl S., Fresser F., Lobentanz E., Baier G., and Utermann G. Novel interaction of apolipoprotein (a) with β-2 glycoprotein I mediated by Kringle IV domain. Blood 90 (1997) 1482-1489
11. McLean J.W., Tomlinson J.E., Kuang W.J., Eaton D.L., Chen E.Y., Fless G.M., Scanu A.M., and Lawn R.M. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 330 (1987) 132-137
12. Lijnen H.R. Elements of the fibrinolytic system. Ann. N. Y. Acad. Sci. 902 (2001) 226-236
13. Blank M., Faden D., Tincani A., Kopolovic J., Goldberg I., Gilburd B., Allegri F., Balestrieri G., Valesini G., and Shoenfeld Y. Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice. J. Autoimmun. 7 (1994) 441-445
14. Monroy V., and Ruiz B.H. Participation of the dengue virus in the fibrinolytic process. Virus Genes 21 (2000) 197-208
15. Sottrup-Jensen L., Claeys H., Zajdel M., Petersen T.E., and Magnusson S. The primary structure of human plasminogen: isolation of two lysine-binding fragments and one "mini" plasminogen (MW, 38,000) by elastase-catalysed-specific limited proteolysis. Prog. Chem. Fibrinol. Thromb. 3 (1978) 191-209
16. Alarcón-Segovia D., and Sanchez-Guerrero J. Primary anti-phospholipid syndrome. J. Rheumatol. 16 (1989) 482-488
17. NACCESS, version 2.1.1. Department of Biochemistry and Molecular Biology, University College London 1996.
18. Tyndall J.D.A., and Fairlie D.P. Conformational homogeneity in molecular recognition by proteolytic enzymes. J. Mol. Recognit. 12 (1999) 363-370
19. Selisko B., Licea A.F., Becerril B., Zamudio F., Possani L.D., and Horjales E. Antibody BCF2 against scorpion toxin Cn2 from Centuroides noxius Hoffmann: primary structure and three-dimensional model as free Fv fragment and complexed with its antigen. Proteins 37 (1999) 130-143
20. Brünger A.T., Kuriyan J., and Karplus M. Crystallographic R-factor refinement by molecular dynamics. Science 235 (1987) 458-460
21. Insightll, version 95.0.5, Biosym/MSI., San Diego, California 1995.
22. Vakser I.A. Low-resolution docking: prediction of complexes for under-determinated structures. Biopolymers 39 (1996) 455-464
23. Fleury V., and Anglés-Cano E. Characterization of the binding of plasminogen to fibrin surfaces: the role of carboxy-terminal lysines. Biochemistry 30 (1991) 7630-7638
24. 2 glycoprotein I autoantibodies: possible mechanism for thrombosis in patients with antiphospholipid syndrome. Br. J. Haematol. 119 (2002) 781-788
25. 2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome. EMBO J. 18 (1999) 6228-6239
26. 2-glycoprotein I: a marker of cerebral infarct and a novel role in the negative feedback pathway of extrinsic fibrinolysis. Blood 103 (2004) 3766-3772
27. An S.S.A., Carreño C., Marti D.N., Schaller J., Albericio F., and LLinas M. Lysine-50 is a likely site for anchoring the plasminogen N-terminal peptide to lysine-binding kringles. Protein Sci. 7 (1998) 1960-1969
28. Cockell C.S., Marshall J.M., Dawson K.M., Cederholm-Williams S.A., and Ponting C.P. Evidence that the conformation of unliganded human plasminogen is maintained via an intramolecular interaction between the lysine-binding site of kringle 5 and the N-terminal peptide. Biochem. J. 333 (1968) 99-105
29. 2-glycoprotein I is proteolytically cleaved in vivo upon activation of fibrinolysis. Thromb. Haemost. 81 (1999) 87-95
30. Nesheim M., Walker J., Wang W., Boffa M., Horrevoets A., and Bajzar L. Modulation of fibrin cofactor activity in plasminogen activation. Ann. N. Y. Acad. Sci. 936 (2001) 247-260
31. Esmon C.T. The protein C pathway. Chest 124 (2003) 26S-32S
32. Simantov R., LaSala J.M., Lo S.K., Gharavi A.E., Sammaritano L.R., Salmon J.E., and Silverstein R.L. Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J. Clin. Invest. 96 (1995) 2211-2219